BioSpace News Archive

Halberd Corp. (OTC PINK: HALB ) was recently included in a Momentum Observer article on Covid-19 along with big pharma companies Pfizer, Moderna, BioNTech and AstraZeneca .

Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today it has screened the first patients in a global trial of its oral insulin capsule ORMD-0801 for the treatment of Nonalcoholic steatohepatitis (NASH).

Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that Meghna Malik, Ph.D., Senior Director, will present at the 4th CRISPR AgBio Congress which is being held December 1-3, 2020 as a virtual event.

Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate endogenous signaling pathways, including the endocannabinoid system, today announced the appointment of drug discovery and development veteran Gregory R. Reyes, M.D., Ph.D. to the Company’s Board of Directors, effective November 30, 2020.

Rhinomed Ltd invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com

3D printing leader Stratasys Ltd. (NASDAQ: SSYS) has enhanced its J750 Digital Anatomy™ 3D printer with advanced bone capabilities that don’t just look real but are actually biomechanically realistic, backed by clinical research. The software upgrade enables the systems to mimic porous bone structures, f

Muno-Vax Biotechnologies, together with manufacturer Natstim, Ltd of Sofia, Bulgaria, has developed products that promote immune health - including supporting respiratory health, men’s prostate health, and oral health.

Financing led by Blumberg Capital supports Segmed’s mission to aggregate medical data for research in support of improving healthcare around the world

Taiho Oncology, Inc. and Astex Pharmaceuticals, Inc. today announced that data for oral decitabine and cedazuridine (INQOVI® [decitabine and cedazuridine] 35mg/100mg tablets) in intermediate and high-risk myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML) will be presented during the 62nd Annual American Society of Hematology Meeting and Exposition (ASH 2020),

PDI, a global leader in infection prevention product and service solutions, today announced the appointment of Keyne Monson as Chief Commercial Officer (CCO).